BOSTON--(BUSINESS WIRE)-- A Boston jury has sided with Paul and Kathryn Lovell in a lawsuit against cosmetic behemoth Johnson & Johnson (NYSE:JNJ) that asserted Mr. Lovell’s mesothelioma was directly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback